Literature DB >> 22024076

99mTc-Galactosyl sialyl albumin (GSA) scintigram adjusts hepatic resection range in ICG based estimation.

Yukio Kamohara1, Mitsuhisa Takatsuki, Masaaki Hidaka, Akihiko Soyama, Takashi Kanematsu, Susumu Eguchi.   

Abstract

BACKGROUND/AIMS: Indocyanin Green (ICG)-based diagnosis is widely accepted in determination of hepatic resection range, however, we frequently encounter scattered results of preoperative assessment. The aim of this study was to clarify the role of 99mTc Galactosyl sialyl albumin (GSA) scintigram in the decision of the resection range.
METHODOLOGY: One hundred and eighty patients who underwent liver resection were included in this study. The patients were divided according to ICGR15 value as follows; Group 1 (n=100): ICG R15 <15%, Group 2 (n=32): ICGR15 15-20%, Group 3 (n=32): ICGR15 20-25% and Group 4 (n=8): ICGR15 >25%. Each group was divided into two subgroups by their GSA-LHL 0.9 levels and compared with regards to liver function, portal pressure and HAI score of background liver. The frequency of complications was also compared to previous cases without GSA-LHL estimation (n=64).
RESULTS: In Groups 2 and 3, the GSA-LHL ≥ 0.9 subgroup showed better platelet counts, portal pressure and lower HAI score. In groups of GSA-LHL ≥ 0.9, platelet counts showed higher value between below 20% of ICGR15 and above that, while GSA-LHL<0.9 showed no difference in groups exceeding 15% of ICGR15. Overall complications occurred less in GSA-LHL ≥ 0.9 compared to previous cases without GSA-LHL estimation.
CONCLUSIONS: Levels of GSA-LHL reflects severity of portal hypertension in moderately damaged liver preoperatively and could contribute to the decision of the range of resection with low morbidity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22024076     DOI: 10.5754/hge11211

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  3 in total

1.  Significance of (99m)Tc-GSA liver scintigraphy in liver surgery and transplantation.

Authors:  Taku Iida; Shintaro Yagi; Tomohide Hori; Shinji Uemoto
Journal:  Ann Transl Med       Date:  2015-02

2.  Changes in the Role and Mode of Liver Resection for Hepatocellular Carcinoma Over 20 Years: A Single-Center Analysis.

Authors:  Susumu Eguchi; Masaaki Hidaka; Tota Kugiyama; Akihiko Soyama; Takanobu Hara; Kantoku Nagakawa; Tomohiko Adachi; Takayuki Tanaka; Tomoko Yoshimoto; Takashi Hamada; Hajime Matsushima; Sinichiro Ito; Kengo Kanetaka
Journal:  World J Surg       Date:  2021-01-25       Impact factor: 3.352

3.  Long-term outcomes of living-donor liver transplantation, hepatic resection, and local therapy for hepatocellular carcinoma with three <3-cm nodules in a single institute.

Authors:  Masaaki Hidaka; Takanobu Hara; Akihiko Soyama; Tomohiko Adachi; Hajime Matsushima; Takayuki Tanaka; Hideki Ishimaru; Hisamitsu Miyaaki; Kazuhiko Nakao; Susumu Eguchi
Journal:  JGH Open       Date:  2022-06-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.